Prizvalve Pro™ Transcatheter Aortic Valve Replacement Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prizvalve Pro™ Transcatheter Aortic Valve Replacement Study — Stella

Home/Aortic Valve Stenosis/

View on ClinicalTrials.gov

Recruiting

Back to Aortic Valve Stenosis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Shanghai NewMed Medical Co., Ltd., Shanghai

Key details

Sponsor

Shanghai NewMed Medical Co., Ltd.

Collaborators

The General Hospital of Northern Theater Command, West China Hospital

Enrollment target

~73 participants

Started

July 2023

Primary completion

June 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

65 Years and older

Last updated November 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.